MJM Skin Ltd

2021-04-012022-03-312022-03-31false08695571MJM Skin Ltd2022-12-2086220iso4217:GBPxbrli:pure086955712021-04-01086955712022-03-31086955712021-04-012022-03-31086955712020-04-01086955712021-03-31086955712020-04-012021-03-3108695571bus:SmallEntities2021-04-012022-03-3108695571bus:AuditExempt-NoAccountantsReport2021-04-012022-03-3108695571bus:AbridgedAccounts2021-04-012022-03-3108695571bus:PrivateLimitedCompanyLtd2021-04-012022-03-3108695571core:WithinOneYear2022-03-3108695571core:AfterOneYear2022-03-3108695571core:WithinOneYear2021-03-3108695571core:AfterOneYear2021-03-3108695571core:ShareCapital2022-03-3108695571core:SharePremium2022-03-3108695571core:RevaluationReserve2022-03-3108695571core:OtherReservesSubtotal2022-03-3108695571core:RetainedEarningsAccumulatedLosses2022-03-3108695571core:ShareCapital2021-03-3108695571core:SharePremium2021-03-3108695571core:RevaluationReserve2021-03-3108695571core:OtherReservesSubtotal2021-03-3108695571core:RetainedEarningsAccumulatedLosses2021-03-3108695571core:LandBuildings2022-03-3108695571core:PlantMachinery2022-03-3108695571core:Vehicles2022-03-3108695571core:FurnitureFittings2022-03-3108695571core:OfficeEquipment2022-03-3108695571core:NetGoodwill2022-03-3108695571core:IntangibleAssetsOtherThanGoodwill2022-03-3108695571core:ListedExchangeTraded2022-03-3108695571core:UnlistedNon-exchangeTraded2022-03-3108695571core:LandBuildings2021-03-3108695571core:PlantMachinery2021-03-3108695571core:Vehicles2021-03-3108695571core:FurnitureFittings2021-03-3108695571core:OfficeEquipment2021-03-3108695571core:NetGoodwill2021-03-3108695571core:IntangibleAssetsOtherThanGoodwill2021-03-3108695571core:ListedExchangeTraded2021-03-3108695571core:UnlistedNon-exchangeTraded2021-03-3108695571core:LandBuildings2021-04-012022-03-3108695571core:PlantMachinery2021-04-012022-03-3108695571core:Vehicles2021-04-012022-03-3108695571core:FurnitureFittings2021-04-012022-03-3108695571core:OfficeEquipment2021-04-012022-03-3108695571core:NetGoodwill2021-04-012022-03-3108695571core:IntangibleAssetsOtherThanGoodwill2021-04-012022-03-3108695571core:ListedExchangeTraded2021-04-012022-03-3108695571core:UnlistedNon-exchangeTraded2021-04-012022-03-3108695571core:MoreThanFiveYears2021-04-012022-03-3108695571core:Non-currentFinancialInstruments2022-03-3108695571core:Non-currentFinancialInstruments2021-03-3108695571dpl:CostSales2021-04-012022-03-3108695571dpl:DistributionCosts2021-04-012022-03-3108695571dpl:AdministrativeExpenses2021-04-012022-03-3108695571core:LandBuildings2021-04-012022-03-3108695571core:PlantMachinery2021-04-012022-03-3108695571core:Vehicles2021-04-012022-03-3108695571core:FurnitureFittings2021-04-012022-03-3108695571core:OfficeEquipment2021-04-012022-03-3108695571core:NetGoodwill2021-04-012022-03-3108695571core:IntangibleAssetsOtherThanGoodwill2021-04-012022-03-3108695571dpl:GroupUndertakings2021-04-012022-03-3108695571dpl:ParticipatingInterests2021-04-012022-03-3108695571dpl:GroupUndertakingscore:ListedExchangeTraded2021-04-012022-03-3108695571core:ListedExchangeTraded2021-04-012022-03-3108695571dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-04-012022-03-3108695571core:UnlistedNon-exchangeTraded2021-04-012022-03-3108695571dpl:CostSales2020-04-012021-03-3108695571dpl:DistributionCosts2020-04-012021-03-3108695571dpl:AdministrativeExpenses2020-04-012021-03-3108695571core:LandBuildings2020-04-012021-03-3108695571core:PlantMachinery2020-04-012021-03-3108695571core:Vehicles2020-04-012021-03-3108695571core:FurnitureFittings2020-04-012021-03-3108695571core:OfficeEquipment2020-04-012021-03-3108695571core:NetGoodwill2020-04-012021-03-3108695571core:IntangibleAssetsOtherThanGoodwill2020-04-012021-03-3108695571dpl:GroupUndertakings2020-04-012021-03-3108695571dpl:ParticipatingInterests2020-04-012021-03-3108695571dpl:GroupUndertakingscore:ListedExchangeTraded2020-04-012021-03-3108695571core:ListedExchangeTraded2020-04-012021-03-3108695571dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2020-04-012021-03-3108695571core:UnlistedNon-exchangeTraded2020-04-012021-03-3108695571core:NetGoodwill2022-03-3108695571core:IntangibleAssetsOtherThanGoodwill2022-03-3108695571core:LandBuildings2022-03-3108695571core:PlantMachinery2022-03-3108695571core:Vehicles2022-03-3108695571core:FurnitureFittings2022-03-3108695571core:OfficeEquipment2022-03-3108695571core:AfterOneYear2022-03-3108695571core:WithinOneYear2022-03-3108695571core:ListedExchangeTraded2022-03-3108695571core:UnlistedNon-exchangeTraded2022-03-3108695571core:ShareCapital2022-03-3108695571core:SharePremium2022-03-3108695571core:RevaluationReserve2022-03-3108695571core:OtherReservesSubtotal2022-03-3108695571core:RetainedEarningsAccumulatedLosses2022-03-3108695571core:NetGoodwill2021-03-3108695571core:IntangibleAssetsOtherThanGoodwill2021-03-3108695571core:LandBuildings2021-03-3108695571core:PlantMachinery2021-03-3108695571core:Vehicles2021-03-3108695571core:FurnitureFittings2021-03-3108695571core:OfficeEquipment2021-03-3108695571core:AfterOneYear2021-03-3108695571core:WithinOneYear2021-03-3108695571core:ListedExchangeTraded2021-03-3108695571core:UnlistedNon-exchangeTraded2021-03-3108695571core:ShareCapital2021-03-3108695571core:SharePremium2021-03-3108695571core:RevaluationReserve2021-03-3108695571core:OtherReservesSubtotal2021-03-3108695571core:RetainedEarningsAccumulatedLosses2021-03-3108695571core:NetGoodwill2020-04-0108695571core:IntangibleAssetsOtherThanGoodwill2020-04-0108695571core:LandBuildings2020-04-0108695571core:PlantMachinery2020-04-0108695571core:Vehicles2020-04-0108695571core:FurnitureFittings2020-04-0108695571core:OfficeEquipment2020-04-0108695571core:AfterOneYear2020-04-0108695571core:WithinOneYear2020-04-0108695571core:ListedExchangeTraded2020-04-0108695571core:UnlistedNon-exchangeTraded2020-04-0108695571core:ShareCapital2020-04-0108695571core:SharePremium2020-04-0108695571core:RevaluationReserve2020-04-0108695571core:OtherReservesSubtotal2020-04-0108695571core:RetainedEarningsAccumulatedLosses2020-04-0108695571core:AfterOneYear2021-04-012022-03-3108695571core:WithinOneYear2021-04-012022-03-3108695571core:Non-currentFinancialInstrumentscore:CostValuation2021-04-012022-03-3108695571core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2021-04-012022-03-3108695571core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2021-04-012022-03-3108695571core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2021-04-012022-03-3108695571core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2021-04-012022-03-3108695571core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2021-04-012022-03-3108695571core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2021-04-012022-03-3108695571core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2021-04-012022-03-3108695571core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2021-04-012022-03-3108695571core:Non-currentFinancialInstrumentscore:CostValuation2022-03-3108695571core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-3108695571core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-3108695571core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-3108695571core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-3108695571core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-3108695571core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-3108695571core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-3108695571core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-3108695571core:Non-currentFinancialInstrumentscore:CostValuation2021-03-3108695571core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2021-03-3108695571core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2021-03-3108695571core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2021-03-3108695571core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2021-03-3108695571core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2021-03-3108695571core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2021-03-3108695571core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2021-03-3108695571core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2021-03-3108695571bus:Director12021-04-012022-03-3108695571bus:Director22021-04-012022-03-31

MJM Skin Ltd

Registered Number
08695571
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2022

MJM Skin Ltd

Company Information
for the year from 1 April 2021 to 31 March 2022


Directors	Mohungoo, Muhammad Javed, Dr
	Sorefan, Nesha Bibi, Dr


Registered Address	33 Tranby Lane
	Swanland
	North Ferriby
	HU14 3NE


Registered Number	08695571 (England and Wales)

MJM Skin Ltd

Balance Sheet as at
31 March 2022

	Notes	2022		2021
		£	£	£	£
Fixed assets
Tangible assets	5		10,487		10,281
Investments	6		10		10
			10,497		10,291
Current assets
Debtors		109,814		113,167
Cash at bank and on hand		495,541		306,037
		605,355		419,204
Creditors amounts falling due within one year		(62,019)		(42,319)
Net current assets (liabilities)			543,336		376,885
Total assets less current liabilities			553,833		387,176
Net assets			553,833		387,176
Capital and reserves
Called up share capital			10		10
Profit and loss account			553,823		387,166
Shareholders' funds			553,833		387,176

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. The directors have chosen to not file a copy of the company’s profit and loss account.
The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved and authorised for issue by the Board of Directors on 20 December 2022, and are signed on its behalf by:

Mohungoo, Muhammad Javed, Dr
Director
Registered Company No. 08695571

MJM Skin Ltd

Notes to the Financial Statements
for the year ended 31 March 2022

1.	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	Compliance with applicable reporting framework
	The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

3.	Accounting policies

	Property, plant and equipment policy
	Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

	Revenue recognition policy
	Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

Revenue recognition policy

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Foreign currency translation and operations policy
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

Foreign currency translation and operations policy

Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

	Investments policy
	Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

Investments policy

Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

	Employee benefits policy
	Contributions to defined contribution plans are expensed in the period to which they relate.

4.	Employee information


		2022		2021
	Average number of employees during the year	1		0

5.	Property, plant and equipment

		Total
		£
	Cost or valuation
	At 01 April 21	20,598
	Additions	3,627
	At 31 March 22	24,225
	Depreciation and impairment
	At 01 April 21	10,317
	Charge for year	3,421
	At 31 March 22	13,738
	Net book value
	At 31 March 22	10,487
	At 31 March 21	10,281

6.	Fixed asset investments

		Total
		£
	Cost or valuation
	At 01 April 21	10
	At 31 March 22	10
	Net book value
	At 31 March 22	10
	At 31 March 21	10

7.	Description of nature of transactions and balances with related parties
	The company holds 100% of the share capital of MJM Brigg Limited (company number 083304296). The amounts owing to the parent company at the balance sheet date was £100,752 (£100,343 - 2021).